Literature DB >> 1880437

Symptoms of pancreatic cancer.

R L Krech, D Walsh.   

Abstract

We describe the symptoms, physical findings, treatment interventions, risk factors, and length of survival in persons with pancreatic cancer referred to a palliative care service (PCS) in a tertiary care facility. Data were collected prospectively over a 2-yr period using a standard clinical assessment tool in 39 patients with unresectable pancreatic cancer. Common symptoms include pain (82%), anorexia (64%), early satiety (62%), xerostomia and sleep problems (both 54%), and weight loss (51%). Analyzed retrospectively, 82% had at least one known risk factor for the development of pancreatic cancer. Twenty-five people presented to the PCS within 1 mo of diagnosis; in this group, length of survival was analyzed according to the presence of specific symptoms, and a significant inverse relationship between the presence of dyspnea and length of survival was found. As there is no effective treatment for surgically unresectable pancreatic cancer, palliation of common symptoms should be the primary emphasis of therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1880437     DOI: 10.1016/0885-3924(91)90027-2

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  22 in total

1.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

2.  Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practice.

Authors:  Hellie Lithoxopoulou; Konstantinos Zarogoulidis; Sevasti Bostantzopoulou; Ellada Eleftheriadou; Paul Zarogoulidis; Haidong Huang; Konstantinos Porpodis; Ioannis Kioumis; Theodora Tsiouda; Lonny Yarmus; Theodore Kontakiotis
Journal:  Support Care Cancer       Date:  2014-03-22       Impact factor: 3.603

Review 3.  Risk factors for pancreatic adenocarcinoma: are we ready for screening and surveillance?

Authors:  Randall Brand; Claudius Mahr
Journal:  Curr Gastroenterol Rep       Date:  2005-05

Review 4.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

Review 5.  Dyspnea: assessment and treatment.

Authors:  M Farncombe
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

6.  Feeding patients following pancreaticoduodenectomy: a UK national survey.

Authors:  Mary Phillips; Jeffrey T Lordan; Neville Menezes; Nariman D Karanjia
Journal:  Ann R Coll Surg Engl       Date:  2009-04-30       Impact factor: 1.891

7.  Pain sensation in pancreatic diseases is not uniform: the different facets of pancreatic pain.

Authors:  Jan G D'Haese; Mark Hartel; Ihsan Ekin Demir; Ulf Hinz; Frank Bergmann; Markus W Büchler; Helmut Friess; Güralp O Ceyhan
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets.

Authors:  Andi Wangzhou; Candler Paige; Sanjay V Neerukonda; Dhananjay K Naik; Moeno Kume; Eric T David; Gregory Dussor; Pradipta R Ray; Theodore J Price
Journal:  Sci Signal       Date:  2021-03-16       Impact factor: 8.192

9.  Health Is Belonging: Lived Experiences during Recovery after Pancreaticoduodenectomy.

Authors:  Thomas Andersson; Kristin Falk; Kristofer Bjerså; Anna Forsberg
Journal:  ISRN Nurs       Date:  2012-12-05

10.  Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pancreatic Cancer: A Prospective Pilot Study of Safety Using 10 mL versus 20 mL Alcohol.

Authors:  Julia K Leblanc; Susan Rawl; Michelle Juan; Cynthia Johnson; Kurt Kroenke; Lee McHenry; Stuart Sherman; Kathy McGreevy; Mohammad Al-Haddad; John Dewitt
Journal:  Diagn Ther Endosc       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.